Cipher Pharmaceuticals Inc.

CPH.TO

$16.83+$0.37 +2.25%At close · July 31

Price1Y range $12.85 – $19.74

Valuations

Estimation history is only available for connected users.

Financial Ratios

vs. 4-yr trend

RATIO TREND TTM

Free Cash Flow Ratios

'23 → TTM

58.90%

Net Income Margin Ratios

'23 → TTM

60.60%

Return on Equity Ratios

'23 → TTM

25.94%

Return on Asset Ratios

'23 → TTM

7.95%

Growth

Total Revenue YoY Growth 28.91%

Diluted EPS YoY Growth 227.70%

Cash from Ops YoY Growth 40.77%

Ask about CPH.TO

Ask the documents

No research uploaded for this stock yet. Check back later.

Key stats

FCF / Sales 58.9%

Net margin 60.6%

Return on equity 25.9%

Profile

Sector Health Care

Industry Pharmaceuticals, Biotechnology & Life Sciences

Country Canada

Exchange TSX

Website Visit site

About

Cipher Pharmaceuticals Inc. is a Canadian specialty pharmaceutical company focused on acquiring, developing, and commercializing novel formulations of existing drugs for unmet medical needs. The company manages clinical development and regulatory approval processes and markets products directly in Canada or through partners in the U.S. and South America, with a focus on dermatology and hospital acute care therapeutics. Cipher is headquartered in Mississauga, Ontario, and has been operating since 2000.